Hormone replacement therapy and mortality in 52- to 70-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study

European Journal of Endocrinology

Volumn 154, Issue 1, 2006, Pages 101-107

  Pentti, Kati ^a   Honkanen, Risto ^a   Tuppurainen, Marjo T ^a   Sandini, Lorenzo ^a   Kröger, Heikki ^a   Saarikoski, Seppo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CAUSE OF DEATH; CLINICAL TRIAL; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEALTH HAZARD; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; MORTALITY; OSTEOPOROSIS; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; CONTROLLED STUDY; DISEASE ASSOCIATION; PROSPECTIVE STUDY; TREATMENT DURATION;

AGED; BREAST NEOPLASMS; COHORT STUDIES; CORONARY DISEASE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FINLAND; HUMANS; LEVONORGESTREL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORETHINDRONE; POSTMENOPAUSE; PROSPECTIVE STUDIES;

EID: 32844463501     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02059     Document Type: Article

References (25)

1. Writing Group for the Women's Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 2002 288 321-333.
2. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN III, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wend J, for the WHIMS Investigators, Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Journal of the American Medical Association 2003 289 2651-2662.
3. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D, for the WHIMS Investigators, Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Initiative Memory Study: a randomized controlled trial. Journal of the American Medical Association 2003 289 2663-2672.
4. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S Mysiw WJ, for the WHI Investigators, Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. Journal of the American Medical Association 2003 289 2673-2684.
5. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E Cuchman M, for the WHI Investigators, Estrogen plus progestin and the risk of coronary heart disease. New England Journal of Medicine 2003 349 523-534.
6. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B & Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Journal of the American Medical Association 1998 280 605-613.
7. Million Women Study Collaborators, Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003 362 419-427.
8. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Funchs C, Hankinson SE, Hunter DJ, Hennekens CH & Speizer FE. Postmenopausal hormone therapy and mortality. New England Journal of Medicine 1997 336 1769-1775.
9. Barrett-Connor E. Hormone replacement therapy. British Medical Journal 1998 317 457-461.
10. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL & Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Annals of Internal Medicine 1992 117 1016-1037.
11. Lauritzen C. Clinical use of estrogens and progestogens. Maturitas 1990 12 199-214.
12. Komulainen MH, Kröger H, Tuppurainen MT, Heikkinen AM, Alhava E, Honkanen R & Saarikoski S. HRT and vitamin D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas 1998 31 45-54.
13. Sourander L, Rajala T, Raiha I, Makinen J, Erkkola R & Helenius H. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on estrogen replacement therapy (ERT). Lancet 1998 352 1965-1969.
14. Bush TL, Whiteman M & Flaws JA. Hormone replacement therapy and breast cancer: a qualitative review. Obstetrics and Gynecology 2001 98 498-508.
15. Barrett-Connor E & Grady D. Hormone replacement therapy, heart disease, and other considerations. Annual Review of Public Health 1998 19 55-72.
16. Causes of Death. Helsinki: Statistics Finland, 2002. (www.statfin.stat.fi/statweb/health/causes of death 1969-2003).
17. Lahti RA & Penttila A. The validity of death certificates: routine validation of death certification and its effects on mortality statistics. Forensic Science International 2001 115 15-32.
18. Posthuma WF, Westendorp RG & Vandenbroucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? British Medical Journal 1994 398 1268-1269.
19. Matthews KA, Kuller LH, Wing RR, Meilahn EN & Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? American Journal of Epidemiology 1996 143 971-978.
20. Hormone replacement therapy, Clinical Synthesis Panel on HRT. Lancet 1999 354 152-155.
21. Rodriquez C, Calle EE, Patel AV, Tatham LM, Jacobs EJ & Thun MJ. Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women. American Journal of Epidemiology 2001 153 145-152.
22. Causes of Death. Helsinki: Statistics Finland, 1995.
23. Causes of Death. Helsinki: Statistics Finland, 2000.
24. Tuppurainen M & Saarikoski S. Estrogens and ageing. Advances in Neurology 2003 91 101-106.
25. Løkkegaard E, Pedersen AT, Heitmann BL, Jovanovich Z, Keiding N, Hundrup YA, Obel EB & Ottesen B. Relation between hormone replacement therapy and ischaemic heart disease in women; prospective observational study. British Medical Journal 2003 326 426-431.